Interior Minister Alain Berset, who announced the news on Wednesday, said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year.
He added that several potential suppliers of the vaccine were considered, but it was not possible to say when a suitable product will be ready for distribution at some point next year.
The government has already placed reservations for several million shots of vaccine from the British-Swedish firm, AstraZeneca, and from the United States pharma company Moderna.
It is also in negotiations with Pfizer/Biontech and hopes to strike a deal for the delivery of another three million vaccines shortly.
However, Berset cautioned that the national regulator Swissmedic, will have to examine and approve a product before it can be distributed.
Vaccination strategy
In a first phase, the government aims to immunise people with a health risk. Berset reiterated there were no plans to declare vaccinations mandatory across the country.
Preparations coordinated by the armed forces are underway to organise the logistics for distributing the vaccines across the country when one or several products will be ready.
“Our primary goal is to improve the current health situation,” he said at a news conference on Wednesday.
Health officials estimate about 60-70% of the population must be inoculated against the new coronavirus to get the pandemic under control.
Berset said the current infection figures in Switzerland remained “alarming” even as the number of confirmed daily cases has begun to stabilise over the past few days.
On Wednesday, the Federal Office for Public Health reported 8,270 new cases of Covid-19 infections bringing the total number up to more than 243,000 cases.
Berset said it was crucial to reduce the coronavirus reproduction rate well beyond 1 to prevent overburdening hospitals and health staff.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Uri voters clear path for hotel and marina complex in central Switzerland
This content was published on
Voters in canton Uri in central Switzerland have rejected a Green Party initiative aimed at regulating the development of the lakeside site in Isleten.
Valais voters reject plan to achieve carbon neutrality by 2040
This content was published on
Voters in canton Valais in southern Switzerland have turned down a proposal for the region to achieve carbon neutrality by 2040.
Swiss central banker wants to boost equity to head off risks
This content was published on
Equity levels at the Swiss National Bank (SNB) are much too low for the risks its large balance sheet poses, according to Martin Schlegel.
Beer sales in Switzerland watered down by bad weather
This content was published on
The past brewing year fell through in Switzerland, partly due to the bad weather. Beer sales shrank again. For the first time, per capita consumption fell below the 50 liter mark.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Why Swiss participation in WHO’s Covid-19 vaccine plan matters
This content was published on
As the second coronavirus wave makes finding vaccines even more urgent, we look at Swiss participation in the WHO's vaccine pool.
This content was published on
Switzerland confirms participation in WHO COVAX initiative aimed at ensuring equitable access to Covid-19 vaccines when they are approved.
This content was published on
The Swiss therapeutic products agency has begun reviewing another anti-Covid 19 vaccine in the rolling submission procedure.
Swiss factory rushes to prepare for Moderna Covid-19 vaccine
This content was published on
Workers are racing to set up production lines at the Lonza factory in Visp to be able to start making a vaccine for US firm Moderna later this year.
Half of Swiss would get vaccinated against Covid-19
This content was published on
If there were an efficient vaccination against coronavirus, every second person in Switzerland would take it, says a survey.
Lausanne hospital test chosen for coronavirus study
This content was published on
A test developed at Lausanne university hospital has been chosen for wide-scale coronavirus antibody studies of the Swiss population.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.